By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arcturus Therapeutics 

3210 Merryfield Row

San Diego  California  92121  U.S.A.
Phone: 858-242-1526 Fax: n/a


Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA delivery technologies.

Key Statistics

Ownership: Private

Web Site: Arcturus Therapeutics
Employees: n/a


Company News
Arcturus Therapeutics To Receive Up To $3 Million From Cystic Fibrosis Foundation Therapeutics, Inc. To Advance A Novel LUNAR-Formulated mRNA CFTR Therapeutic 5/30/2017 6:30:31 AM
Arcturus Therapeutics Announces Collaboration With Takeda (TKPYY) To Develop RNA-Based Therapeutics For The Treatment Of Nonalcoholic Steatohepatitis (NASH) 12/7/2016 6:44:32 AM
Arcturus Therapeutics To Report Identification Of LUNAR-HBV, A Potent Combination Of Three UNA Oligomers Targeting All Hepatitis B Virus Genotypes At The AASLD Liver Meeting 2016 10/3/2016 9:06:59 AM
BIO2016: Arcturus Therapeutics To Present At 2016 BIO International Convention In San Francisco 6/1/2016 4:13:51 PM
Arcturus Therapeutics Receives Intent To Grant Notice From The European Patent Office For Their Unlocked Nucleomonomer Agent (UNA) Technology 3/16/2016 6:14:53 AM
Arcturus Therapeutics Announces The Appointment Of Drew Weissman M.D., Ph.D. To The Scientific Advisory Board 11/3/2015 6:58:06 AM
Arcturus Therapeutics Stands to Collect Up to $1.66 Billion from Rare Disease Pact with Ultragenyx (RARE) 10/29/2015 6:30:20 AM
Arcturus Therapeutics Announces Strategic Collaboration With Johnson & Johnson Innovation (JNJ) To Discover And Develop RNA Medicines For Defined Indications 6/11/2015 6:49:52 AM
Arcturus Therapeutics To Present Messenger RNA Pipeline At The 33rd Annual J.P. Morgan Healthcare Conference And The 7th Annual Biotech Showcase 1/7/2015 8:41:12 AM
Arcturus Therapeutics Announces The Appointment Of Michael R. Hodges, M.D. To The Scientific Advisory Board 12/9/2014 7:30:49 AM